Long-term impact of multivessel disease on cause-specific mortality after ST elevation myocardial infarction treated with reperfusion therapy

Structured PICO

Does multivessel disease impact long-term cause-specific mortality in patients with STEMI treated with reperfusion therapy?

Population

Patients with ST elevation myocardial infarction (STEMI) treated with reperfusion therapy

Intervention

Multivessel disease (MVD)

Comparator

Non-multivessel disease (non-MVD)

Outcome

Long-term cause-specific mortality (total mortality, sudden death, and death caused by heart failure)hard clinical

In STEMI patients treated with reperfusion therapy, multivessel disease independently predicts long-term mortality specifically due to heart failure, rather than sudden death or overall mortality.

Abstract

Patients with STEMI and MVD have a higher long-term mortality than do patients with non-MVD. MVD is not an independent predictor of long-term total mortality or sudden death. However, MVD is a very strong and independent predictor of long-term death caused by heart failure.

Bookmark

View Full Paper

Cite This Study

Schaaf et al. (Thu,) studied this question.

synapsesocial.com/papers/69effa364f6a06657c21dee9 https://doi.org/https://doi.org/10.1136/hrt.2005.086058

Bookmark

View Full Paper